Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.
Publication
, Journal Article
Krishnan, R; Cella, D; Leonardi, C; Papp, K; Gottlieb, AB; Dunn, M; Chiou, CF; Patel, V; Jahreis, A
Published in: Br J Dermatol
December 2007
Duke Scholars
Published In
Br J Dermatol
DOI
ISSN
0007-0963
Publication Date
December 2007
Volume
157
Issue
6
Start / End Page
1275 / 1277
Location
England
Related Subject Headings
- Treatment Outcome
- Receptors, Tumor Necrosis Factor
- Psoriasis
- Male
- Immunoglobulin G
- Humans
- Female
- Fatigue
- Etanercept
- Double-Blind Method
Citation
APA
Chicago
ICMJE
MLA
NLM
Krishnan, R., Cella, D., Leonardi, C., Papp, K., Gottlieb, A. B., Dunn, M., … Jahreis, A. (2007). Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol, 157(6), 1275–1277. https://doi.org/10.1111/j.1365-2133.2007.08205.x
Krishnan, R., D. Cella, C. Leonardi, K. Papp, A. B. Gottlieb, M. Dunn, C. F. Chiou, V. Patel, and A. Jahreis. “Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.” Br J Dermatol 157, no. 6 (December 2007): 1275–77. https://doi.org/10.1111/j.1365-2133.2007.08205.x.
Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, et al. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol. 2007 Dec;157(6):1275–7.
Krishnan, R., et al. “Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks.” Br J Dermatol, vol. 157, no. 6, Dec. 2007, pp. 1275–77. Pubmed, doi:10.1111/j.1365-2133.2007.08205.x.
Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, Chiou CF, Patel V, Jahreis A. Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol. 2007 Dec;157(6):1275–1277.
Published In
Br J Dermatol
DOI
ISSN
0007-0963
Publication Date
December 2007
Volume
157
Issue
6
Start / End Page
1275 / 1277
Location
England
Related Subject Headings
- Treatment Outcome
- Receptors, Tumor Necrosis Factor
- Psoriasis
- Male
- Immunoglobulin G
- Humans
- Female
- Fatigue
- Etanercept
- Double-Blind Method